Celegene

Will Access and Label Expansion Drive Celgene’s Otezla Growth?
Yahoo/Market Realist
Fri, 03/18/16 - 10:37 am
Otezla
Celegene
Celgene names Mark Alles to CEO position, ending internal contest
Fierce Biotech
Sun, 01/17/16 - 12:14 pm
Celegene
Eyeing buyout, Celgene paying $105M to partner on Lycera's anti-cancer T cell tech
Fierce Biotech
Tue, 06/9/15 - 12:00 pm
Celegene
Lycera
M&A
cancer
T-cells
Analysis of FDA side-effect reports flags Sanofi, Celgene meds
Fierce Pharma
Tue, 01/28/14 - 11:37 am
Celegene
FDA
Sanofi
side effects
Pomalyst
Tecfidera
Biogen Idec
Aubagio
Celgene's And Osiris' IP Positions Weakened By Pluristem's Pivotal Patent
Seeking Alpha
Thu, 09/12/13 - 10:20 am
Celegene
Osiris
stem cells
Pluristem
patents
placental-based cells
Celgene Riding Molecular Biology 'Revolution': CEO
CNBC
Fri, 04/13/12 - 09:56 am
Celegene
molecular biology
Robert Hugin
Celgene to Issue $1.25 Billion of Debt in Debut Sale After Boosting Size
Bloomberg
Mon, 10/4/10 - 07:46 pm
Celegene
bonds
NICE deal, Celegene
InVivo
Tue, 02/10/09 - 08:27 am
NICE
UK
Celegene
Revlimid